Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body weight over a year, researchers reported Monday in The New England Journal of Medicine.
Getting approval from your insurance company before a procedure or treatment may soon get a little easier.
THC-infused gummies and vape pens will stay legal in Texas—at least for now.
A recent discovery could transform our understanding of bone health maintenance and pave the way for potential treatments for bone diseases, including osteoporosis. Researchers at the University of São Paulo's Ribeirão Preto School of Dentistry (FORP-USP) in Brazil have identified a protein called agrin that plays an essential role in preserving bone mass and quality.
A new study involving 121 former elite rowers from Australia has revealed one in five develops atrial fibrillation (AFib).
Today, high school students worldwide face unprecedented levels of stress as they navigate academic pressures, issues with social identity, and future career decisions.
Researchers from the University of Plymouth have identified proteins that fuel the growth of the most common type of brain tumor, a discovery that could ultimately lead to less invasive treatments for patients.
People in the UK are eating too much meat—especially processed meat—according to a recent report from the Food Foundation, a UK charity.
A study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the tumor immune microenvironment (TIME) plays a critical role in the progression of nasopharyngeal carcinoma (NPC) commonly known as nose cancer. These insights are paving the way for precision oncology approaches, some of which are currently used in clinical trials at NCCS. The findings are published in Cell Reports Medicine.
Scientists from Cincinnati Children's and colleagues based in Japan report achieving a major step forward in organoid technology: producing liver tissue that grows its own internal blood vessels.
In a major breakthrough, a team of researchers from The City College of New York and Memorial Sloan Kettering Cancer Center (MSKCC) has developed a new AI model that can detect breast cancer in MRI images and pinpoint the location of tumors.
An AI-assisted model developed by researchers from the University of Missouri School of Medicine and the School of Engineering can take low-quality MRI heart scans and turn them into high-quality images, while reducing the time needed to scan the heart by about 90%.
A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of Medicine at the University of Pennsylvania published in the New England Journal of Medicine.
People living in more disadvantaged neighborhoods may be more likely to have biomarkers for inflammation and Alzheimer's disease, according to a study published in Neurology. The study does not prove that neighborhood factors cause these biomarkers: it only shows an association.
In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a molecule within HIV itself can be manipulated and amplified to force the virus into long-term dormancy, a state in which HIV does not replicate.
The skin acts as the body's first line of defense against external threats. However, as we age, the epidermis—the outermost layer of skin—gradually becomes thinner and loses its protective strength. About 90% of the cells in this layer are keratinocytes, which originate from deeper layers of the epidermis and migrate upward, ultimately forming the skin's protective barrier.
There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better understand the development of this common disease, researchers from Bochum and Bonn have taken a close look at defective valves.
An international study has shown that a drug called selumetinib can reduce the pain and size of tumors caused in adults by neurofibromatosis type 1 (NF1), a rare genetic disease for which there is currently no effective pharmacological treatment.
A new study led by scientists from BGI Genomics' Institute of Intelligent Medical Research (IIMR) has identified early biomarkers and disease neurons associated with Alzheimer's Disease (AD) pathology.